Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Location status: Recruiting
Location contact
Rachel Bernier
CONTACT
NCT Number: NCT04296071
Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.
Interested in participating?
Request InfoUp to 12 month
All sexes
Observational
Boston, Massachusetts, 02115, United States
Location status: Recruiting
Rachel Bernier
CONTACT
Acute lung injury (ALI) is frequently associated with the use of extracorporeal circulation during cardiopulmonary bypass (CPB) surgery and develops postoperatively in 2-3% of cardiac surgical patients. Histological evidence shows that CPB increases pulmonary vascular permeability and extravascular lung water content while diminishing pulmonary compliance. Furthermore, some patients can develop acute respiratory distress syndrome, which has a mortality rate of 50-70%. Recruitment of intrapulmonary neutrophils is a characteristic of ALI following CPB. Blood contact with non-physiological surfaces, cooling and rewarming and mechanical shear stress activate neutrophils. The recruitment of activated neutrophils from blood vessels to local tissue involves a chain of well-coordinated events, including adhesion, tethering, rolling and crawling, followed by trans-endothelial and trans-epithelial migration. Activation of sequestered neutrophils causes the release of specific proteolytic enzymes and oxygen free radicals, which leads to increased alveolar-endothelial permeability and parenchymal damage. During CPB, the lungs are almost completely excluded from the systemic circulation, which causes the blood within them to be almost 'static'. Pulmonary tissue hypoxia and re-oxygenation combined with vascular ischemia and reperfusion induce the generation of chemokines, which contributes to subsequent injury by accumulating and entrapping activated neutrophils. The accumuled and entrapped activated neutrophils in the lungs and the subsequent release of toxic substances render the lungs highly susceptible to this damage. However, the mechanism that drives neutrophil migration to the lungs after CPB is not well studied. This study will delineate the mechanisms of neutrophil migration to the lung and subsequent lung injury after CPB.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood and tracheal aspirates will be collected
Time frame: 2 years
We will analyze neutrophil profiles in the blood and tracheal aspirates
Time frame: 2 years
We will measure the levels of chemoattractants in the blood and tracheal aspirates
Time frame: 2 years
We will measure neutrophil functions from the blood and tracheal aspirates
Contact information is provided by the study sponsor or research team.
Koichi Yuki, MD
CONTACT
Sophia Koutsogiannaki, PhD
CONTACT
Sophia Koutsogiannaki
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04989439
Computed Tomography, Electric Impedance
Vienna, Austria
View Trial DetailsNCT06686251
Cardiomegaly, Cardiovascular Diseases
Curitiba, Paraná, Brazil
View Trial DetailsNCT06296173
Anesthesia, Atelectasis
Ottawa, Ontario, Canada
View Trial DetailsNCT06203405
Critical Illness, Disease Attributes
Bangkok, Thailand
View Trial Details